Nashai Biotech

Nashai Biotech is a biotechnology company focused on the research, development, and commercialization of high-purity natural bioactive compounds. The company specializes in polyphenols, most notably high-purity Resveratrol and Pterostilbene, which are targeted at metabolic health, longevity, and inflammatory conditions. Nashai collaborates with academic institutions to conduct clinical trials validating the efficacy of their ingredients in managing conditions such as Type 2 diabetes and obesity. Their business model encompasses both the supply of premium ingredients to the global market and the advancement of proprietary therapeutic formulations.